1998
DOI: 10.1016/s0304-3940(98)00379-6
|View full text |Cite
|
Sign up to set email alerts
|

NTI4F: a non-peptide fluorescent probe selective for functional delta opioid receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
37
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(41 citation statements)
references
References 17 publications
0
37
0
Order By: Relevance
“…47,48,59,[80][81][82] In previous studies [33][34][35][36] it had been shown that the implementation of a linker on the guanidinyl NH leads to molecules which can retain affinity, antagonistic activity and selectivity for the KOR. Inspired by these studies, and also by investigations highlighting the contribution of the linker's length and physicochemical properties in avoiding non-specific binding and preserving the pharmacological profile of the prototype ligand, 60,61,[83][84][85] we designed three sets of fluorescent probes: a) compounds 9a and 9b, which bear a 11-bond aliphatic linker (Scheme 1); b) compound 13, which bears a 17-bond linker with the incorporation of a diglycine moiety (Scheme 2); c) compounds 17a and 17b, which bears a 23-bond linker with the incorporation of a tetraglycine moiety (Scheme 2). Regarding their synthesis, an orthogonal approach was necessary in order to simultaneously accommodate the selective protection of primary amines and the protection of the guanidinyl NH throughout the synthetic scheme.…”
Section: Introductionmentioning
confidence: 99%
“…47,48,59,[80][81][82] In previous studies [33][34][35][36] it had been shown that the implementation of a linker on the guanidinyl NH leads to molecules which can retain affinity, antagonistic activity and selectivity for the KOR. Inspired by these studies, and also by investigations highlighting the contribution of the linker's length and physicochemical properties in avoiding non-specific binding and preserving the pharmacological profile of the prototype ligand, 60,61,[83][84][85] we designed three sets of fluorescent probes: a) compounds 9a and 9b, which bear a 11-bond aliphatic linker (Scheme 1); b) compound 13, which bears a 17-bond linker with the incorporation of a diglycine moiety (Scheme 2); c) compounds 17a and 17b, which bears a 23-bond linker with the incorporation of a tetraglycine moiety (Scheme 2). Regarding their synthesis, an orthogonal approach was necessary in order to simultaneously accommodate the selective protection of primary amines and the protection of the guanidinyl NH throughout the synthetic scheme.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, a wide range of fluorescent conjugates of delta agonists and antagonists have been synthesized and are commercially available (Cell Aura Technologies Ltd. and Cisbio Bioassays). Fluorescent antagonists have proved useful to examine delta opioid receptor distribution in living cells (Kshirsagar et al, 1998; Balboni et al, 2004; Cohen et al, 2016); while agonists have been used to study delta opioid receptor inter-nalization and trafficking in vivo (Arttamangkul et al, 2000; Cahill et al, 2001; Lee et al, 2002). …”
Section: Introductionmentioning
confidence: 99%
“…Fluorescent ligands selective for δORs mostly consist of peptide‐based, natural products as pharmacophores, which are not part of our summary. Kshirsagar and colleagues developed δOR‐selective fluorescent ligands 93a‐b by merging naltrindole (NTI) and fluorescein (Scheme 53A) [191] . They found that substitution at 7′ position and incorporation of a tetraglycyl‐linker improved selectivity, yielding a fluorescent probe for δOR imaging.…”
Section: Fluorescent Ligands For Gpcrsmentioning
confidence: 99%